CA51372-3C - 0x000000000000710A

Male & Females of Non-Childbearing Potential

Canvas

* Stipend may pay up to reflected amount.
Start Date: 
November 12, 2026 - 7:15am
End Date: 
December 14, 2026 - 2:20pm

Study Details

Study Number: CA51372
Group Number: 3C
Study Requirement: Healthy Normal Male and Female
Stipend: up to $4,500.00

Study Criteria

Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to improve motor function in patients with muscular dystrophy.
Route of Administration: Oral
Blood Draws: 19

Study Schedule

Schedule Type: Short Term
Study Length: 5 Night Stay & 2 Phone Calls

Screening Dates:

Event Day Event Date
Wednesday 11/4/2026

Doctor Exam Dates:

Event Day Event Date
Wednesday 11/4/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 11/12/2026 7:15:00 AM Tuesday 11/17/2026 11:45:00 AM 9 Phoenix
Check-In Thursday 11/12/2026 7:15:00 AM Tuesday 11/17/2026 11:45:00 AM 1 Phoenix
Check-In Thursday 11/12/2026 11:20:00 AM Wednesday 11/18/2026 11:50:00 AM 10 Phoenix
Phone participant Sunday 11/22/2026 2:15:00 PM 1 Phoenix
Phone participant Sunday 11/22/2026 2:15:00 PM 9 Phoenix
Phone participant Monday 11/23/2026 2:20:00 PM 10 Phoenix
Phone participant Sunday 12/13/2026 2:15:00 PM 1 Phoenix
Phone participant Sunday 12/13/2026 2:15:00 PM 9 Phoenix
Phone participant Monday 12/14/2026 2:20:00 PM 10 Phoenix